XTL
XTL is a pharmaceutical company specializing in the development of targeted therapeutics for the treatment of autoimmune diseases. Founded in 1993, XTL has focused on advancing innovative treatments through clinical trials and research collaborations with leading medical institutions. The company is dedicated to improving the lives of patients suffering from chronic conditions through the development of cutting-edge therapies.